Novan faces delisting from Nasdaq


After years and ups and downs while the company has been trying to push out their nitric oxide candidates, Novan now faces a delisting threat due to steadily decreasing stock value.

Previous Advocate Aurora taking full ownership of Marinette hospital
Next Miami Jewish Health pulls out of project with Graham Companies